Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KDM5 histone demethylases repress immune response via suppression of STING
Lizhen Wu, Jian Cao, Wesley L. Cai, et al.
PLoS Biology (2018) Vol. 16, Iss. 8, pp. e2006134-e2006134
Open Access | Times Cited: 139

Showing 26-50 of 139 citing articles:

The Dual Function of KDM5C in Both Gene Transcriptional Activation and Repression Promotes Breast Cancer Cell Growth and Tumorigenesis
Haifeng Shen, Wenjuan Zhang, Ying Huang, et al.
Advanced Science (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 49
Comparative transcriptome analysis reveals key epigenetic targets in SARS-CoV-2 infection
Marisol Salgado-Albarrán, Erick I. Navarro‐Delgado, Aylin Del Moral‐Morales, et al.
npj Systems Biology and Applications (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
Kyung‐min Lee, Chang‐Ching Lin, Alberto Servetto, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 7, pp. 829-843
Open Access | Times Cited: 32
The histone demethylase KDM5C controls female bone mass by promoting energy metabolism in osteoclasts
Huadie Liu, Lukai Zhai, Ye Liu, et al.
Science Advances (2023) Vol. 9, Iss. 14
Open Access | Times Cited: 22
Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription
Yunkai Zhang, Ying Gao, Yuyu Jiang, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1279-1292
Open Access | Times Cited: 19
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Marisabel Mecca, Simona Picerno, Salvatore Cortellino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2750-2750
Open Access | Times Cited: 8
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution
Rebecca E. Hamlin, S. Pienkos, Leslie Chan, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 8
Targeting KDM4 family epigenetically triggers antitumour immunity via enhancing tumour‐intrinsic innate sensing and immunogenicity
Mayu Sun, Xiaoyu Han, Jinyang Li, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 7
Mutant huntingtin protein induces MLH1 degradation, DNA hyperexcision, and cGAS–STING-dependent apoptosis
Xiao Sun, L Liu, Chao Wu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 7
KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations
Xiaoni Liu, Shang‐Min Zhang, Meaghan K. McGeary, et al.
Molecular Cancer Therapeutics (2018) Vol. 18, Iss. 3, pp. 706-717
Open Access | Times Cited: 51
X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis
Rossella Tricarico, Émmanuelle Nicolas, Michael J. Hall, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 21, pp. 5567-5578
Open Access | Times Cited: 50
Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes cell culture
Miriane de Oliveira, Maria Teresa De Síbio, Lucas Solla Mathias, et al.
Molecular and Cellular Endocrinology (2020) Vol. 515, pp. 110917-110917
Open Access | Times Cited: 49
The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy
Goran Micevic, Marcus Bosenberg, Qin Yan
Clinical Cancer Research (2022) Vol. 29, Iss. 7, pp. 1173-1182
Open Access | Times Cited: 28
Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
Yang Yu, Jingyang Liu, Cun Liu, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 3043-3043
Open Access | Times Cited: 27
High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies
Lavinia Ghiani, Susanna Chiocca
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3483-3483
Open Access | Times Cited: 24
H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy
Chu Xiao, Tao Fan, Yujia Zheng, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 8, pp. e005693-e005693
Open Access | Times Cited: 16
Cancer cell-specific cGAS/STING Signaling pathway in the era of advancing cancer cell biology
Vijay Kumar, Caitlin Bauer, John H. Stewart
European Journal of Cell Biology (2023) Vol. 102, Iss. 3, pp. 151338-151338
Open Access | Times Cited: 15
Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform ‘cold’ tumors into ‘hot’ tumors
Xiaohong Ying, Qiaohui Chen, Yongqi Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition
Molly Gale, Yao Li, Jian Cao, et al.
Cancer Research (2019) Vol. 80, Iss. 3, pp. 524-535
Open Access | Times Cited: 40
Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer
Dinoop Ravindran Menon, Heinz Hammerlindl, Joachim Torrano, et al.
Theranostics (2020) Vol. 10, Iss. 14, pp. 6261-6277
Open Access | Times Cited: 38
Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres
Sandra Segura‐Bayona, Marina Villamor-Payà, Camille Stephan‐Otto Attolini, et al.
Cell Reports (2020) Vol. 32, Iss. 5, pp. 107983-107983
Open Access | Times Cited: 35
Y disruption, autosomal hypomethylation and poor male lung cancer survival
Saffron A.G. Willis‐Owen, Clara Domingo‐Sabugo, E. Starren, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30
COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks
Mankgopo Magdeline Kgatle, Ismaheel O. Lawal, Gabriel T. Mashabela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 30
BRD4 inhibition boosts the therapeutic effects of epidermal growth factor receptor-targeted chimeric antigen receptor T cells in glioblastoma
Lin Xia, Junyi Liu, Zaozao Zheng, et al.
Molecular Therapy (2021) Vol. 29, Iss. 10, pp. 3011-3026
Open Access | Times Cited: 28
Targeting the loss of cGAS/STING signaling in cancer
Nobunari Sasaki, Mizuki Homme, Shunsuke Kitajima
Cancer Science (2023) Vol. 114, Iss. 10, pp. 3806-3815
Open Access | Times Cited: 13

Scroll to top